Amgen
Amgen
About

Amgen is one of the world’s leading biotechnology companies. Amgen is a values-based company, deeply rooted in science and innovation to transform new ideas and discoveries into medicines for patients with serious illnesses.

At Amgen, they believe in a “biology first” approach. They use cutting-edge science and technology to study the subtlest biological mechanisms in search of therapies that will improve the lives of those who suffer from serious diseases. Amgen believes the cure for disease can be found inside each and every one of us.

Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Their belief—and the core of their strategy—is that innovative, highly differentiated medicines that provide large clinical benefits in addressing serious diseases are medicines that will not only help patients, but also will help reduce the social and economic burden of disease in society today.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology innovator since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.

Read more
Similar organizations
European Medicines Agency (EMA)
European Medicines Agency (EMA)
GovernmentService Providers
1 open position
Youth Challenge International (YCI)
Youth Challenge International (YCI)
Implementing NGOService Providers
1 open position
UN Technology Bank for the Least Developed Countries
1 open position

Company Offices

  • United States (headquarters)
  • Thousand Oaks
  • One Amgen Center Drive